Search Results for "New Antidepressants On The Market 2013"

03:33 EST 18th December 2014 | BioPortfolio

Original Source: New Research Report on Antidepressants Market to 2018 by MarketResearchReports

Albany, NY, February 24, 2013 --(PR.com)-- Antidepressants Market to 2018 Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives GBI Research, the leading business intelligence provider, has released its latest research, Antidepressants Market to 2018 Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives, which provides i...

Matching Channels

Heterocyclic antidepressants

Veregen

Veregen® is an ointment used to treat external genital warts. In the USA, Germany, Austria, Spain, Switzerland and Serbia, Veregen® is already marketed by our partners. Sales and marketing p...

Telehealth

Telehealth uses communication devices such as computers, mobiles and tablets to deliver healthcare. For example, many patients monitor their condition using a telehealth computer which can take read...

Nutraceuticals

Nutraceuticals are food products with added nutritional and health benefits. They include fortified foods and can have added nutrients or compounds that aid weight-loss. It is a booming market area....

Dental Prosthetics

Dental Prosthetics are prosthetic implants for the mouth, and can be for cosmetic or dental reasons. The market is increasing, and technology is improving the quality of them.

Matching News

New Research on Antidepressants During Pregnancy

Antidepressants during pregnancy could lead to childhood obesity, study finds.

Autophagy and antidepressants

FK506 binding protein 51 (FKBP51) regulates acute and chronic effects of treatment with antidepressants via autophagic pathways (processes by which cells break down and recycle their components) in mi...

One in 10 women in England takes antidepressants, survey shows

One in 10 women in England reported taking antidepressants in one week in 2013, double the rate among men, a survey has found.The annual Health Survey for England1 found that 11% of women took...

Overprescribing antidepressants: where's the evidence?

Is the United Kingdom in the grip of an antidepressants epidemic? We are certainly gripped by an epidemic of the media writing about them. The past few months have seen reports of more...

Antidepressants increase, rather than decrease, risk of suicidal behaviours in younger patients

Lu and colleagues’ study contains four substantial flaws, any of which would be fatal to the authors’ premise that Food and Drug Administration warnings about suicide risks of antidepressants led ...

Studies promoting use of antidepressants for postoperative pain may be premature, review finds

Antidepressants are known to provide effective pain relief for various chronic pain conditions; however, the jury is still out on their use in treating the millions of patients who suffer from acute o...

ADHD study flags pre-natal use of antidepressants

Children born to women who took antidepressants during pregnancy are statistically likelier to develop the mental disorder called ADHD, researchers said on Tuesday.

Antidepressants during pregnancy safe for baby’s heart, according to new research

NEW YORK (Reuters Health) - Records from nearly a million women and their newborn children offer new evidence that common antidepressants taken during pregnancy do not increase the risk of...

Matching PubMed Articles

Antidepressants and Tamoxifen: an Unrecognized Interaction.

The interaction between tamoxifen and antidepressants which are CYP2D6 inhibitors is unknown, as shown in our study in which these antidepressants are prescribed to 11% of women receiving tamoxifen.

Oscillations in rational economies.

Economic (business) cycles are some of the most noted features of market economies, also ranked among the most serious of economic problems. Despite long historical persistence, the nature and the ori...

New drugs and indications in 2013: little real progress but regulatory authorities take some positive steps.

2013 saw few therapeutic innovations that really benefitted patients; once again, marketing authorisations were too often granted despite inadequate clinical data. The French health authorities implem...

To Conduct Clinical Trial in China, To Go or Not To Go.

In last 10 years, more and more clinical trials have come to China because of potential market/easy access of patient and cost-effectiveness, but looking back, there is less change on the regulatory r...

Antidepressants: use, adherence and awareness among medical students.

This study assessed the degree of adherence and drug-related awareness and opinions regarding the importance of guidance with respect to treatment among medical students who use antidepressants. It is...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement